Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Ukraine Now Using Drone Boats To Attack Russian Riverine Targets - 2This Week In Space podcast: Episode 186 — Snow on the Moon?
- 3Find the Advantages of Positive Nurturing: Supporting Cheerful and Sound Kids
- 4Where should we send a real 'Hail Mary' spacecraft? A new study has the answers
- 5$2,000 tariff rebate checks? 50-year mortgages? Making sense of Trump's new 'affordability' proposals.
- IDF kills senior PIJ Gaza City Brigade cmdr. who infiltrated Kibbutz Nahal Oz on Oct. 7
- Israel’s 'Stonehenge’ not alone with near 30 similar sites, satellite imagery reveals
- Step by step instructions to Deal with Your Time While Chasing after an Internet based Degree
- Meet the astronauts about to make history on flight around the moon
- Manual for Tracking down Spending plan Agreeable Travel Objections
- Famous Restroom Beautifying Styles For 2024
- The Best 10 Innovation Advancements of the Year
- Hyundai Is Keeping the i30 Alive While America Keeps Losing Cars Like It
- Watch interstellar comet 3I/ATLAS speed away from the sun in free telescope livestream on Nov. 16
